In Rakova et al.’s report, both RNA sequencing and MFC testing using PBMCs illustrated that AML patients with TIM-3high on NK cells displayed significantly higher GZMB levels than those with TIM-3low [15]. The gene discussed is GZMB; the disease is acute myeloid leukemia.